(NYSE:ENFN),(NASDAQ:ITCI),(NASDAQ:HEES),(NYSE:SSTK), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Enfusion, Inc. (NYSE: ENFN)'s sale to Clearwater Analytics for $5.85 per share in cash and $5.40 […]

The acquisition underscores YMX Logistics' commitment to redefining yard operations for enterprise shippers across North America. YMX Logistics, a national provider of integrated yard logistics operations, announced today the acquisition of Yard Commander, a leading yard management system (YMS). Founded in 2011 by Enrico Notte and Aaron Barnhard, Yard Commander is deployed across hundreds of

Research conducted in partnership with Ipsos introduces a new paradigm in leveraging psychographic insights to influence consumer financial behaviors. The financial services industry is experiencing a transformation, thanks to a recent study by Psympl, conducted in partnership with Ipsos. This research has introduced psychographic profiling into the realm of financial decision-making, offering a fresh perspective

Cmbio™, a global leader in multi-omics science and digital biology, announces a strategic partnership with Nimble Science, to deliver first in class high-quality, multi-omic data insights from the small intestine. Through this initiative, Nimble's SIMBA™ GI Health Data Platform will be combined with Cmbio's advanced expertise in multi-omics data integration to advance microbiome research and

IntelliGenome, an innovative molecular diagnostic solutions provider, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its CRISPR-Tuberculosis (TB) Blood Test. This test is the first qualitative real-time polymerase chain reaction (PCR) assay to combine CRISPR technology, designed to detect Mycobacterium tuberculosis (Mtb) cell-free DNA in

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=124053&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=124052&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Zeta Global Holdings Corp. (NYSE:ZETA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zeta-global-holdings-corp-lawsuit-submission-form-2?prid=124050&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marqeta-inc-lawsuit-submission-form?prid=124049&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

AUSTIN, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) — On the heels of President Trump's inauguration parade in which he doubled down on his promise to make service-industry workers' tips non-taxable, Requite Microfinance has launched Tap 'n Tip, a cutting-edge digital tipping platform designed to empower workers in the leisure, hospitality, and transportation industries by creating